Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Ropivacaine × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Pain 3 Pain, Postoperative 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Postoperative Complications 1 Ovarian Cysts 1 Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Ovarian Cancer 1 Abdominal Neoplasms 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02256228 2019-01-15

IPLA

Göteborg University

Phase 3 Completed

Agnosia, Neoplasms, Pain, Pain, Postoperative, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡